1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Diagnostic Breakthroughs for Neurodegenerative Diseases (TechVision) 

Diagnostic breakthroughs for neurodegenerative diseases (TechVision) : R&D Portfolio Analysis of Neurodiagnostic Innovations

This research service covers key technological trends and developments in diagnostics for neurodegenerative diseases, which are likely to have a high impact in the near future. The technologies present across the global neurodiagnostic industry have been covered under neurobiomarkers, neuroimaging and neuroinformatics segments. While providing brief overviews for each technology, the research service also covers industrial snapshots and emerging innovations in the neurodiagnostic markets. The research service also includes drivers & challenges, market adoption, collaborations, funding and patent scenarios for neurodiagnostic technologies.

Key Findings : Global Neurodiagnostics Segment

Neuroimaging technologies continue to remain the gold-standard for neurodiagnostic applications and they constitute the largest market segment in this space. Advancements in this sector encompass the emergence of novel hybrid imaging technologies that offer smooth work flow integration across various imaging modalities and software analysis platforms. Another significant trend in this space is the development of novel radiotracers for neurological biomarkers that aid diagnostic and clinical applications for diseases such as Alzheimer’s Disease (AD).

There are several assay platforms that are currently available for the detection of neurological biomarkers, especially for diseases such as dementia and AD. However, new biomarker discoveries and advanced diagnostic platforms for Parkinson’s disease (PD), traumatic brain injury (TBI), and other dementias are expected in the near future. Emerging technological trends in this sector include the use of optical scanning techniques for detecting retinal biomarkers for neurological diseases.

While there are several software platforms that are available for processing neuroimaging data, limited algorithms are currently available for diagnostic and clinical analyses. There are, however, several cloud-based storage platforms for exchange and analyses of a vast amount global neurological data. Furthermore, as more companies are looking to develop quantitative software techniques for the detection and analyses of various neuropathologies, this sector is optimally poised for a major growth spurt in the near future.

Increasing collaborations across the pharmaceutical and diagnostic segments are fueling the growth of companion diagnostic market for neurological disorders, thus setting the stage for wider market outreach. Such collaborations for patient selection during clinical trials are likely to mirror the growth phase observed for the cancer companion diagnostics marke

Table Of Contents

Diagnostic Breakthroughs for Neurodegenerative Diseases (TechVision) 
1 EXECUTIVE SUMMARY

Executive Summary
1. Scope of Research
2. Research Methodology
3. Research Methodology
4. Key Findings

2 RandD PORTFOLIO ANALYSIS

RandD Portfolio Analysis
1. Overview of Neurodegenerative Diseases
2. Neurodegenerative Disease Diagnostics-Segmentation
3. Biomarker-based Diagnostics: Overview
4. Key Biomarkers for Neurodiagnostics
5. Emerging Biomarker Diagnostics in Neurology (1/2)
6. Emerging Biomarker Diagnostics in Neurology (2/2)
7. Neuroimaging Technologies: Overview
8. Neuroimaging Technologies
9. Neuroimaging Technologies
10. Neuroimaging Technologies
11. Neuroimaging Technologies: Innovation Ecosystems
12. Neuroinformatics: Overview
13. Neuroinformatics: Innovation Ecosystems

3 FUNDING ANALYSIS

Funding Analysis
1. Venture Investment Scenario for Neurobiomarkers
2. Public Funding Landscape for Neurobiomarker Projects
3. Public Funding Landscape for Neurobiomarker Projects

4 ENVIRONMENTAL ANALYSIS

Environmental Analysis
1. Key Technological Drivers and Challenges
2. Key Technological Drivers
3. Key Technological Challenges
4. Key Market Drivers and Challenges
5. Key Market Drivers
6. Key Market Challenges
7. Clinical Trials Analysis
8. Adoption Scenario for Biomarker Diagnostics
9. Adoption Scenario for Neuroimaging Techniques
10. Adoption Scenario for Neuroinformatic Tools

5 STRATEGIC INSIGHTS

Strategic Insights
1. Overview of the Collaborative Landscape
2. Product Development Partnerships-Diagnostics
3. Product Development Partnerships-Companion Diagnostics
4. Licensing and Research Collaborations
5. Research Consortia
6. Emerging Technologies
7. Conclusions

6 PATENT ANALYSIS

Patent Analysis
1. Patent Search Scope
2. Patents for Neurodegenerative Diseases-Timeline Overview
3. Global Patent Spread by Assignees
4. Global Patent Spread by Patent Offices

7 KEY CONTACTS AND APPENDIX

Key Contacts and Appendix
1. Key Contacts
2. Appendix I
3. Appendix I
4. Appendix II

8 THE FROST and SULLIVAN STORY

The Frost and Sullivan Story
1. The Frost and Sullivan Story
2. Value Proposition: Future of Your Company and Career
3. Global Perspective
4. Industry Convergence
5. 360º Research Perspective
6. Implementation Excellence
7. Our Blue Ocean Strategy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.